Atlas Trials

Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen

Clinical trial NCT02478632 · COMPLETED

Trial details

NCT number
NCT02478632
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV Infections
Start date
2015-06-12
Primary completion
2016-09-16
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.